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Abstract
Background: Dermanyssus gallinae is the most economically important haematophagous ectoparasite in
commercial egg laying flocks worldwide. It infests the hens during the night where it causes irritation leading to
restlessness, pecking and in extreme cases anaemia and increased cannibalism. Due to an increase in the
occurrence of acaricide-resistant D. gallinae populations, new control strategies are required and vaccination may
offer a sustainable alternative to acaricides. In this study, recombinant forms of D. gallinae tropomyosin (Der g 10)
and paramyosin (Der g 11) were produced, characterised and tested as vaccine candidate molecules.
Methods: The D. gallinae paramyosin (Der g 11) coding sequence was characterised and recombinant versions of
Der g 11 and D. gallinae tropomyosin (Der g 10) were produced. Hens were immunised with the recombinant
proteins and the resulting antibodies were fed to D. gallinae and mite mortality evaluated. Sections of mites were
probed with anti- Der g 11 and Der g 10 antibodies to identify the tissue distribution of these protein in D. gallinae.
Results: The entire coding sequence of Der g 11 was 2,622 bp encoding 874 amino acid residues.
Immunohistochemical staining of mite sections revealed that Der g 10 and Der g 11 were located throughout
D. gallinae tissues. In phylogenetic analyses of these proteins both clustered with orthologues from tick species
rather than with orthologues from astigmatid mites. Antibodies raised in hens against recombinant forms of these
proteins significantly increased D. gallinae mortality, by 19 % for Der g 10 (P < 0.001) and by 23 % for
Der g 11 (P = 0.009) when fed to the mites using an in vitro feeding device.
Conclusions: This study has shown that Der g 10 and Der g 11 were located ubiquitously throughout
D. gallinae and that antibodies raised against recombinant versions of these proteins can be used to
significantly increase D. gallinae mortality in an in vitro feeding assay. When comparing archived data for all
recombinant and native proteins assessed as vaccines using this in vitro feeding assay, Der g 10 and Der g 11 ranked
highly and performed better than some of the pools of native proteins.
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Background
The poultry red mite (PRM), Dermanyssus gallinae
(De Geer), is a blood-feeding ectoparasite that infests
many bird species. From both an economic and welfare
perspective, PRM is the most important ectoparasite
affecting egg-laying hens worldwide [1, 2]. In 2005 it was
estimated that €130 million was lost annually due to PRM
in Europe [3] and it is likely that losses now far exceed
that level. These mites reside in crevices of the furniture
and machinery in the poultry house and emerge in dark-
ness to feed, for short periods of time, on the blood of
hens [4, 5]. Heavy infestations of D. gallinae of more than
200,000 mites per hen can result in anaemia, irritation,
restlessness, feather pecking and, in extreme cases, death
and increased levels of cannibalism [5, 6]. In addition,
D. gallinae is becoming an important occupational health
issue for poultry workers exposed to PRM bites and aller-
gens [7]. Spraying of poultry facilities with chemical acari-
cides is the most widely-used method of control [8].
However, there is an increasing incidence of resistance to
acaricides in D. gallinae [9–11] and the potential for accu-
mulation of acaricide residues in eggs and poultry meat
[12, 13] has resulted in a need for safer alternatives for the
control of PRM. Several alternative methods of control are
available or are in development, for example plant or
fungal extracts, essential oils and vaccination [8].
Vaccination has shown promise for the control of a
number of haematophagous parasites of livestock: The
commercially-available Barbervax® vaccine contains native
Haemonchus contortus gut antigens and has been shown
to significantly reduce clinical disease in sheep during field
use in Australia (reviewed in [14]). In addition, the ecto-
parasite vaccines TickGARD™ and Gavac™, were developed
with the recombinant protein Bm86 as the protective anti-
gen against the tropical cattle tick Rhipicephalus microplus
in Australia and South America, respectively [15]. Bm86
homologues have since been fully characterised in several
other tick species (Rhipicephalus annulus, R. decoloratus,
Haemaphysalis longicornis and Hyalomma marginatum
marginatum [16, 17]) but not in other members of the
Acari. To date no conserved orthologues of the Bm86 anti-
gen have been identified in transcriptomic data of D. galli-
nae [18, 19]. Therefore, other vaccine candidates are
required for the development of a vaccine strategy for
PRM control. One approach used for D. gallinae vaccine
candidate identification has been the rational selection of
antigens based upon their inferred orthology with promis-
ing vaccine candidates in other species [20]. The mite aller-
gens tropomyosin (group 10 allergen) and paramyosin
(group 11 allergen) [21] are microfilament proteins that
facilitate the interaction between actin with myosin and
troponin during filament assembly and contraction. Tropo-
myosin is ubiquitously found in eukaryotic cells and several
tissue-specific isoforms exist [22, 23], whereas paramyosin
is an invertebrate-specific component of the thick filament
of muscles [24]. Tropomyosins are potent mite allergens
[21] and both paramyosin and tropomyosin have shown
promising results as vaccine candidates against a range of
ecto- and endo-parasites including the trematode Schisto-
soma japonica, the filarioid nematode Acanthocheilonema
viteae and the tick Haemaphysalis longicornis [25–28].
Tropomyosin has been characterised in a number of
mite species including Metaseiulus occidentalis (94 and
97 % amino acid identity to D. gallinae tropomyosin for
isoforms 1 (accession XP_003745222) and 2 (accession
XM_003745175), respectively), the house dust mites
(HDM) Dermatophagoides pteronyssinus (85 % identity),
D. farinae (86 % identity) [29, 30] and sheep scab mites
Psoroptes ovis (86 % identity) [21]. There are also several
tick species with orthologues such as R. microplus (89 %
identity) and H. longicornis (88 % identity) [31]. Recom-
binant tropomyosin from H. longicornis was used to im-
munise rabbits and, following tick feeding on vaccinated
animals, significant reductions (P < 0.05) in tick engorge-
ment weights (19.4 %), oviposition (49.5 %), egg mass
(14.7 %) and egg hatching rates (100 %) were seen [27].
Paramyosin has also previously been identified as a
potential vaccine candidate for parasite control: The
native form of paramyosin from S. japonicum was used
to immunise mice and, following challenge with the
parasite, the adult worm burden in immunised mice
compared to control mice was reduced by up to 86 %
[25]. Immunisation of BALB/c mice with a recombinant
cocktail vaccine containing S. japonicum paramyosin
fragments reduced worm burden and liver-stage eggs by
up to 40 and 78 %, respectively following challenge [28].
The aim of the work described here was to investigate
the potential of recombinant versions of D. gallinae
tropomyosin (Der g 10) and paramyosin (Der g 11), to
control the ectoparasite D. gallinae when used to
immunise hens.
Methods
Dermanyssus gallinae collection, extraction of total RNA
and cDNA synthesis
Mixed stage and gender D. gallinae were collected from
a commercial egg production unit and were snap frozen
in liquid nitrogen within 4 h of collection. RNA was
extracted and isolated using TRIZOL® reagent (Invitrogen,
Carlsbad, United States) according to the manufacturer’s
protocol. After DNaseI treatment and subsequent purifi-
cation using RNeasy spin columns (Qiagen, Hilden,
Germany), mRNA was purified from total RNA using the
Poly(A)Purist™ kit (Ambion, Waltham, United States).
Rapid amplification of cDNA ends (RACE)-ready
cDNA was generated using the SMART™ RACE cDNA
Amplification Kit (Clontech, Paris, France) using the
manufacturer’s protocols.
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Characterisation of the genes encoding Der g 11 and
Der g 10
A partial transcriptomic sequence representing the para-
myosin gene Der g 11 was identified in a D. gallinae
Roche 454 sequencing dataset [20]. 5’ and 3’ RACE reac-
tions were performed to amplify the remaining sections
of coding sequence. RACE products were ligated into
pGEM®-T Easy vector (Promega, Madison, United
States) and DNA sequencing performed (Eurofins MWG
Operon) to confirm the coding sequences (CDS). The
full CDS of paramyosin was amplified using gene-
specific oligonucleotide primers (forward, 5'-TTC GGA
TCC GAT GGA GGC CAT CAA GAA TAA GAT G-3'
and reverse, 5'-AGT GCG GCC GCG TAT CCG GTA
AGC TCG GCG AA-3') and employing RACE-ready
cDNA as the template with Advantage® 2 PCR polymer-
ase (Clontech). The resulting paramyosin CDS was
named Der g 11 in accordance with systematic allergen
nomenclature [32] and deposited in the NCBI database
under accession number LT555400. The CDS of the
D. gallinae tropomyosin gene (Der g 10, AM167555)
was previously determined [31].
A homology search (Blastx) was performed using the
NCBI nr database to identify homologues of Der g 10
and Der g 11. The amino acid sequences of the top 20
hits for Der g 11 and Der g 10 were aligned using T-
coffee (Version_11.00.8cbe486) [33, 34], which generated
a neighbour-joining tree drawn according to relation-
ships inferred by the multiple sequence alignment. The
neighbour joining tree was bootstrapped 1,000 times
using ClustalW and viewed in the package MEGA 6.06
[35] (6140226), the degree of bootstrap was shown only
if above 50 %.
Expression and purification of Der g 10 and Der g 11 as
recombinant proteins
The full CDS of Der g 11 and that of Der g 10 were sub-
cloned into pET-SUMO (Invitrogen) and pET-22b(+)
(Novagen, Madison, United States) vectors, respectively in
frame with the vector-encoded polyhistidine tags. Plasmid
DNA was transformed into Esherichia coli BL21-
CodonPlus® (DE3)-RIL competent cells (Stratagene, La
Jolla, United States) and recombinant protein expression
induced with 1 mM IPTG. Recombinant Der g 11 and
Der g 10 were purified from inclusion bodies by nickel
column affinity chromatography using HisTrap™ HP
columns in the presence of 8 M urea (GE Healthcare)
then dialysed against 20 mM phosphate buffer, 0.5 M
NaCl, 2 M urea, pH 7.4. The Pierce BCA™ assay (Thermo
Scientific, Waltham, United States) with bovine serum
albumin standards were used to estimate the protein con-
centration. Eluted proteins were separated by electrophor-
esis on a 4–12 % NuPAGE® Novex Bis-Tris Gel
(Invitrogen) and bands at the appropriate molecular
weight for each protein were excised and analysed using
MALDI-ToF spectroscopy to confirm their identity
(Moredun Proteomics Unit).
Generation of immunoglobulin specific for recombinant
Der g 10 and Der g 11
Female Blackrock hens were injected, into the breast
muscle, with either recombinant Der g 11 or Der g 10
(2 hens for each protein). Each dose comprised 75 μg
of recombinant protein, 200 μg of QuilA adjuvant and
PBS in a final volume of 300 μl. Booster injections
were administered 2 and 4 weeks later. Sera and eggs
were collected pre-immunisation, for use as a negative
controls for Western blotting and in the feeding assay,
and 2 weeks after the third immunisation (week 6),
when the antibody level against the target proteins was
predicted to be at a maximum. IgY was purified from
the egg yolks using the Eggstract kit (Promega) follow-
ing the manufacturer’s instructions and was stored at
-20 °C. IgY concentration was determined using the
Pierce BCA™ assay (Thermo Scientific). Equal amounts
(3 mg/ml) of purified IgY from individual hens were
pooled according to group and time.
All procedures were carried out in accordance with
the UK Animals (Scientific Procedures) Act 1986. The
ethics committee at Moredun Research Institute ratified
the experimental design (08/09).
Immunoblotting of D. gallinae extracts, recombinant
Der g 10 and Der g 11
Proteins were extracted from freshly collected D. gallinae
and fractionated into soluble, membrane-associated,
integral-membrane and insoluble proteins as previously de-
scribed [36]. Each protein fraction (~3 μg total protein per
fraction) and recombinant protein (3 μg) was loaded onto
a 4–12 % NuPAGE® Novex Bis-Tris gel (Invitrogen) and
then separated by electrophoresis. The proteins were elec-
troblotted onto nitrocellulose membranes and probed with
a pool of IgY previously purified from egg yolk was diluted
1:200 with Tris-buffered saline (TBS) to ~30 μg/ml and the
blot was developed as described in Bartley et al. [37].
Immunolocalisation of Der g 10 and Der g 11 in sections
of D. gallinae
Five micron sections of D. gallinae were immobilised
onto glass slides, using the protocol described in
Bartley et al. [37]. Sections were probed with primary
antibodies generated in mice against Blomia tropicalis
paramyosin (Blo t 11) [38] and D. pteronyssinus
tropomyosin (Der p 10) [21]. These antibodies were
previously shown to cross-react with Der g 10 and
Der g 11 in Western blots (data not shown).
The immunolocalisation protocol was as described in
Bartley et al. [39] with the following differences: the
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primary antibodies were diluted 1:200 with TBS for the
mouse monoclonal IgG anti-Blo t 11, whereas the mouse
polyclonal IgG anti-Der p 10 was diluted 1:1000. Bound
antibodies were detected with a Rabbit anti-mouse-IgG/
HRP conjugate (Dako, Glostrup, Denmark; P0260).
Effects of consuming IgY specific for Der g 10 and Der g
11 on D. gallinae mortality
IgY antibodies raised in hens against either Der g 10 and
Der g 11 were fed to pre-conditioned D. gallinae using the
in vitro blood-feeding system described in Wright et al.
[36] and the mortality of mites following feeding was
monitored. Briefly, three groups of mites were fed with a
blood meal prepared by mixing 2 ml fresh heparinised
blood (36 USP units heparin per ml blood) obtained from
D. gallinae-naive Lohmann Brown hens with 1 ml (6 mg)
of a pooled IgY, previously described, purified from egg
yolk collected pre-immunisation (control group) or 2 weeks
after the third immunisation (week 6) with Der g 10
or Der g 11 (test groups). This experiment was re-
peated on three occasions using 10 in vitro chambers
per experimental group. Approximately 200 D. galli-
nae were added to each chamber and 300 μl of blood
containing IgY was added to the reservoir of each
chamber. The chambers were incubated at 40 °C in
darkness with a relative humidity of 75 % overnight.
Mites that had fed during the overnight incubation were
separated into individual wells of a 96-well microtitre plate
(Greiner bio-one, Kremsmunster, Austria), sealed with Aer-
aSeal™ film (Sigma-Aldrich, St. Louis, United States; A9224-
50EA,) and mortality was measured every 24 h for a 4-day
period. The mite mortality data were fitted to a simple
logistic regression model (SLRM), which individually com-
pared the mortality from both test groups (Der g 10 and
Der g 11-immunised) with that of the controls (immunised
with adjuvant only) over the course of the experiment.
Results
Characterisation and phylogenetic relationships of
Der g 10 and Der g 11
The CDS of D. gallinae Der g 11 (Accession number
LT555400) was 2,622 bp, encoding an 874 amino acid
Fig. 1 Relationships between selected sequences of Der g 11 from different invertebrate species. The neighbour-joining tree was bootstrapped
1,000 times using Clustal X and the resulting tree viewed with TreeView. Each node is annotated with a figure indicating the degree of bootstrap
support for each branch. Abbreviations and accession numbers are as follows: Dermanyssus (D. gallinae), Metaseiulus (M. occidentalis;
XP_003744495.1), Rhipicephalus (R. (Boophilus) microplus; AAO20875.1), Haemaphysalis (H. longicornis; AFR32950.1), Ixodes (I. scapularis;
XP_002407289.1), Sarcoptes (Sarcoptes scabiei; ABV54632.1), Sarcoptes 1 (S. scabiei; ACC65584.1), Dermatophagoides (D. farinae; AIO08864.1),
Sarcoptes 2 (S. scabiei; AAK01181.1), Psoroptes (P. ovis; CAJ38271), Chorioptes (Chorioptes panda; ACB30406.1), Dermatophagoides 1 (D. farinae;
AAO73464.1), Chorioptes 1 (C. texanus; ABK54038.1), Blomia; Blomia tropicalis (Q8MUF6.1), Stegodyphus (Stegodyphus mimosarum; KFM81308.1),
Stegodyphus 1 (S. mimosarum; KFM67302.1), Pediculus (P. humanus corporis; XP_002432355.1), Zootermopsis (Zootermopsis nevadensis; KDR08790.1),
Nilaparvata (Nilaparvata lugens; AGI96992.1), Pogonomyrmex (Pogonomyrmex barbatus; XP_011636912.1), Papilio (Papilio xuthus; BAM17768.1)
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sequence. The sequence with highest homology to Der g 11
was from another member of the order Mesostigmata, M.
occidentalis with an amino acid identity of 95 %. The pre-
dicted protein, Der g 11, also had homologues in the tick
species R. microplus, H. longicornis and Ixodes scapularis,
with amino acid identities of 84, 84 and 82 %, respectively
whereas the amino acid identities of Der g 11 with the
orthologous proteins from astigmatid mites were lower at
76 % for Sarcoptes scabiei and 75 % for P. ovis (Fig. 1).
The top two hits when the nucleotide sequence for
Der g 10 was searched against the NCBI nr database using
Blastx were two isoforms of tropomyosin from M. occi-
dentalis with a 97 and 94 % identity to Der g 10, respect-
ively. The next two species with closest homologues were
again the ticks R. microplus and H. longicornis with 89
and 88 % identity, respectively. As with Der g 11, homo-
logues from the astigmatid mite species had lower amino
acid identities to Der g 10 with P. ovis and S. scabiei
tropomyosins being 86 % identical (Fig. 2).
Overall, tropomyosin and paramyosin sequences from
D. gallinae were both most closely related to ortholo-
gues from species belonging to the order Mesostigmata.
Phylogenetic analysis placed Der g 10 and 11 into
discrete clades with the M. occidentalis orthologues
(Figs. 1 and 2), with a stronger inferred relationship with
the tick species compared to the astigmatid mites, which
partitioned separately.
Anatomical distribution of Der g 11 and Der g 10 in
D. gallinae
Immunoblots probed with IgY antibodies raised against
the recombinant forms of Der g 10 and Der g 11
demonstrated the presence of Der g 10 in PBS-soluble,
membrane-associated, integral-membrane and urea-
soluble protein preparations from the mite as well as spe-
cific recognition of the recombinant bacterially-expressed
Der g 10 (Fig. 3a). In contrast, Der g 11 was present only
in the urea-soluble fraction of the native proteins (Fig. 3b).
The recombinant form of Der g 11 was specifically bound
by anti-Der g 11 IgY. The heavy and light chains of IgY
were also detected in the PBS-soluble and membrane-
associated proteins extracted from mites at a molecular
weight of 65 kDa and 25 kDa, respectively, on both immu-
noblots. Lane 11 in Fig. 3a and b show the two recombin-
ant proteins that were used to immunise the hens.
Fig. 2 Relationships between selected sequences of Der g 10 from different invertebrate species. The neighbour-joining tree was bootstrapped
1,000 times using Clustal X and the resulting tree viewed with TreeView. Each node is annotated with a figure indicating the degree of bootstrap
support for each branch. Abbreviations and accession numbers are as follows: Dermanyssus (Dermanyssus gallinae; CAJ44440.1), Metaseiulus (M.
occidentalis; XP_003745223.1), Metaseiulus 1 (M. occidentalis; XP_003745222.1), Rhipicephalus (R. microplus; O97162.1), Haemaphysalis (H. longicornis;
Q8IT89.1), Haemaphysalis 1 (Haemaphysalis qinghaiensis; ABQ96858.1), Blomia (B. tropicalis; ABU97466.1), Lepidoglyphus (Lepidoglyphus destructor
(Q9NFZ4.1)), Psoroptes (P. ovis (CAJ38272.1)), Dermatophagoides (D. farinae; BAA04557.1), Dermatophagoides 1 (D. farinae; Q23939.2), Dermatophagoides 2
(D. farinae; ABU97468.1), Dermatophagoides 3 (D. pteronyssinus; ACI32128.1), Chortoglyphus (Chortoglyphus arcuatus; AEX31649.1), Sarcoptes (S. scabiei;
AFH08744.1), Stegodyphus (S. mimosarum; KFM56635.1), Dermatophagoides 4 (D. farinae; AIO08865.1), Dermatophagoides 5 (D. pteronyssinus; AAB69424.1),
Dermatophagoides 6 (D. pteronyssinus; O18416.1), Aleuroglyphus (Aleuroglyphus ovatus; AAX37287.1), Metaseiulus 2 (M. occidentalis; XP_003745225.1)
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Immunolocalisation of Der g 10 and Der g 11 demon-
strated specific staining of both proteins throughout the
sections in multiple mite tissues, reflecting their roles in
muscle movement and tissue structural integrity (Fig. 4).
For both proteins, there was a high intensity of staining
present in the locomotory muscle bundles compared to
the staining observed in control sections [40].
Effects of ingesting IgY specific for Der g 10 and Der g 11
on D. gallinae mortality
The vaccine potential of recombinant Der g 10 and
Der g 11 was investigated by feeding antibodies against
the proteins to D. gallinae in vitro. Mites were fed a
blood meal enriched with 2 mg/ml of IgY generated
against Der g 10, Der g 11 or IgY from non-
immunised hens to serve as a control. The majority of
D. gallinae mortality occurred within the first 2 days
after feeding (Fig. 5), a mite was considered dead if it
had desiccated. The mite mortality at 24 h was 20 %
(standard error of the mean (SEM) = 11.3 %) for Der g 11
and 19 % (SEM= 7.8 %) for Der g 10, compared to 6 %
(SEM= 3.3 %) mortality observed in the control group. A
further increase in mortality of 10 % for Der g 11 and 7 %
for Der g 10 was seen from 24 to 48 h, with a reduction in
variability between mite groups (SEM reduced to 7.5 and
4.4, respectively). In comparison, the increase in mortality
in the control group was lower at 3 % (SEM= 3.4) during
the same 24 to 48 h time period. Little mortality occurred
after the 48 h time point for any of the groups.
The cumulative mortality of D. gallinae at 96 h after
feeding on either anti-Der g 10 or anti-Der g 11 anti-
bodies was statistically significantly higher than that of
Fig. 3 Immunoblots of native and recombinant Der g 10 and Der g 11 from Dermanyssus gallinae. a Tropomyosin. b Paramyosin. For both
immunoblots: Lanes 1 and 6: Water soluble proteins; Lanes 2 and 7: Membrane associated proteins; Lanes 3 and 8: Integral membrane proteins;
Lanes 4 and 9: Insoluble proteins; Lanes 5 and 10: Recombinant protein; Lane 11: Recombinant protein. Lanes 1–5 were probed with IgY
extracted from egg yolk from hens immunised with either recombinant Der g 10 (a) or Der g 11 (b), and Lanes 6–10 were probed with control
sera. Lane 11 was stained with SimplyBlue safe stain (Invitrogen). Lane M: SeeBlue plus 2 molecular mass markers, in kDa (Invitrogen). Stars
indicate heavy and light chains of IgY in Lanes 1 and 2 for a, and 1, 2, 6 and 7 for b
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the control groups [t = 4.34, df = 22, P < 0.001 for anti-
Der g 10 (19 % mortality); t = 2.89, df = 22, P = 0.009 for
anti-Der g 11 (23 % mortality)].
Discussion
Here we have characterised D. gallinae allergens para-
myosin (Der g 11), tropomyosin (Der g 10) and evalu-
ated their potential as vaccine candidates. We have
shown that recombinant versions of the two muscle-
related proteins can generate IgY responses in hens and
that when these antibodies were fed to D. gallinae, sig-
nificant mortality ensued. Identifying a reliable, afford-
able and easy to administer control method for D.
gallinae would improve the welfare of hens and poultry
workers, increase egg production and reduce costs to
the egg industry. In addition, a safe control strategy for
D. gallinae that does result in potentially toxic residues
in the food chain is desirable and vaccination fulfils all
of those requirements. However, vaccination would not
produce sterile immunity in the chickens, vaccination
would be used as part of an integrated control strategy
that would also include emerging techniques [8].
In recent years, several vaccine candidates have been
identified in D. gallinae using a pragmatic approach
employing successive rounds of native protein fraction-
ation and testing and/or by selecting antigens by their
inferred orthology with protective antigens from other
parasite species [11, 20, 27, 31, 36, 37, 39, 41–44]. Many
of the recombinant D. gallinae antigens or native anti-
gen extracts previously tested for vaccine efficacy using
the in vitro feeding device [36] have produced a statisti-
cally significant increase in D. gallinae mortality after
one blood meal. Table 1 summarises the net increase in
mite mortality 48 h after in vitro feeding on blood
enriched with antibodies raised against the listed D. gal-
linae recombinant proteins or native protein extracts
that have been tested by our group.
In comparison with the net mortality induced by other
vaccine candidates listed in Table 1, Der g 11 had the
fourth highest increase in mortality overall and the sec-
ond highest mortality attributable to immunisation with
a recombinant protein. Der g 10, which had a net in-
crease in mortality of 18.9 %, was the eighth highest
overall and the fifth highest recombinant protein.
Fig. 4 Immunolocalisation of Der g 10 and Der g 11 in sections of Dermanyssus gallinae. a Der g 11. b Der g 10. c No primary antibody control
slide. Abbreviations: dt, digestive tract; fam, feeding associated muscles; lm, locomotory muscle bundles; md, midgut diverticulum; ov, ovaries; ovd,
oviduct; sf, sacculus foemineus; vlm, ventral longitudinal muscle; vm, ventral muscle. Brown staining represents presence of protein
Fig. 5 Mortality of Dermanyssus gallinae. Fed heparinised chicken blood enriched with antibodies against Der g 10 or Der g 11. Mortality was
monitored daily over a 4-day period following feeding. Each point represents cumulative mean percentage mortality and was derived from data
recorded in three independent experiments. The error bars represent the standard error of the mean (SEM)
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Therefore, Der g 11 is one of the best performing re-
combinant vaccine candidates tested to date in terms of
inducing D. gallinae mortality.
When a recombinant form of tropomyosin from the
astigmatid mite S. scabiei was used to immunise rabbits
there was an increase in serum levels of antigen-specific
IgG after immunisation. However, there was no apparent
effect on mite mortality as the infested areas on the rab-
bits increased rapidly and mites were detected in skin
scrapings from both the control groups and the vacci-
nated group [45]. Similarly, when a recombinant version
of H. longicornis tropomyosin was injected into rabbits
there was no impact on tick mortality following
challenge but immunisation with the recombinant H.
longicornis tropomyosin did significantly reduce the en-
gorgement weight (150 mg compared to 186 mg in the
control; P < 0.05), egg laying rate (6 % compared to 56 %
in the controls; P < 0.05) and egg hatching, which was
totally blocked (0 % after vaccination) of ticks feeding on
the immunised hosts [27]. These reproduction-
associated indicators of vaccine efficacy were not mea-
sured in the current study but with further refinement
of the in vitro feeding assay they could be incorporated
into future vaccine efficacy studies.
In vaccine studies with other parasites, using paramyo-
sin and tropomyosin as antigens, a 34 % reduction in A.
viteae adult worm burden was recorded when tropomy-
osin was used to immunise jirds [41] and reductions of
S. japonicum burden of between 23 and 40 % have been
recorded when paramyosin was used to immunise mice
[28]. Paramyosin from the liver fluke Chlonorchis sinen-
sis was also used in a vaccine study where a recombinant
version of the protein was used to immunise rats, which
were then challenged with metacercariae. The faecal egg
counts (51 % of those measured in controls) and worm
burdens (54 % of those measured in the controls) were
significantly reduced by immunisation [42]. When a re-
combinant version of Dictyocaulus viviparus paramyosin
was used to vaccinate cattle it caused a 52 % average re-
duction in larval shedding and a 44 % reduction in worm
burden over two experiments [43].
These studies all used endo-parasitic organisms that
are continually under pressure from the host immune
system. The in vitro feeding assay used herein for an
ectoparasitic organism only offers D. gallinae blood for a
single night, which equates to one blood meal. During
the course of the D. gallinae life-cycle, a mite will feed
multiple times [46], which would frequently expose it to
the host immune system. The percentage mortality ob-
served could therefore increase as D. gallinae feed mul-
tiple times, potentially leading to impact on D. gallinae
populations in a field setting. In addition, as the mortal-
ity of D. gallinae fed anti-Der g 10 and anti-Der g 11
antibodies individually was relatively low these, or other
antigens, may be combined to produce a cocktail vaccine
whose components could act additively or synergistically
to produce a higher level of mortality (e.g. see [47]).
The mechanisms of action behind the mortality-inducing
effects of ingested anti-Der g 10 and anti-Der g 11 are not
yet understood but, for both proteins, antibody-binding to
mite tissues may inhibit the functions of the proteins, lead-
ing to disruption of cytoskeletal function or formation [47].
Evidence has also been found that paramyosin, from Trichi-
nella spiralis, can sequester host C9, reducing cell damage
to the parasite from the host complement cascade, so a vac-
cine based on paramyosin may prevent the parasite from
subverting the host immune response [48]. Both of these
Table 1 Poultry red mite mortality 48 h after feeding on blood
enriched with antibodies. Values shown are for all recombinant
proteins and native protein extracts evaluated at Moredun
Research Institute thus far. Data were normalised by subtracting
the percentage mortality of the mites in the control groups
from the mortality of the mites in the test groups






Whole SME Native 24.0* [20]
IEX-Group-4 Native 23.5* [20]
Deg-VIT-1 Recombinant 21.9* [20]
Der g 11 Recombinant 20.1* Present study
IEX-Group-1 Native 19.5* [20]
Deg-HGP-1 Recombinant 18.9* [20]
Deg-PUF-1 Recombinant 18.4* [20]
Der g 10 Recombinant 16.5* Present study
Deg-CPR-1 Recombinant 14.5 [20]
IEX-Group-3 Native 13.0* [20]
Deg-SRP-1 Recombinant 12.3* [20]
IEX-Group-5 Native 11.4* [20]
PBS-soluble Native 10.1* [36]
Dg-CatD-1 Recombinant 6.9* [39]
Deg-ASP-1 Recombinant 5.6 [20]
Dg-HRF Recombinant 4.1* [37]
Deg-GPD-1 Recombinant 4.1 [20]
Deg-PUF-3 Recombinant 3.5 [20]
Dg-CatL-1 Recombinant 2.6* [39]
Membrane associated Native 2.2 [36]
Deg-PUF-2 Recombinant 0.6 [20]
Urea- soluble Native 0.2 [36]
Integral membrane Native -1.5 [36]
IEX-Group-2 Native -4.2 [20]
Deg-SRP-2 Recombinant -8.2 [20]
*Statistically significant difference (P < 0.05) between mortalities in the control
and antigen test groups in the original study
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actions would ultimately cause cell death and the break-
down of D. gallinae gut. This breakdown of the gut could
explain the characteristic “red leg” phenotype that can be
seen in some of the dead D. gallinae observed [18].
Conclusions
The experiments described in this paper have shown
that tropomyosin and paramyosin are present in D. galli-
nae and, when they were used as immunising antigens
in hens an antibody response was generated against
them, which had a statistically significantly deleterious
effect on the survival of D. gallinae. Therefore, these an-
tigens should be considered as potential vaccine candi-
dates against D. gallinae, the poultry red mite.
Abbreviation
PRM: Poultry red mite
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